Search

everythinglearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Cancer prevention is crucial, with a focus on research and improved screening methods.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

New medications could improve treatment for severe alopecia areata in Australia.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Skin diseases are common in Greece and significantly affect people's lives and well-being.

Thyroid issues can cause alopecia areata.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

No single treatment is clearly effective for central serous chorioretinopathy.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Burn care for the elderly needs improvement, with more research and specific guidelines required.

3D-printed hydrogels show promise in medicine but face challenges in resolution, cell viability, cost, and regulations.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Head and neck melanoma cases rose by 51.1% in young males aged 15-39 from 1995 to 2014.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

New treatments like nanotechnology show promise in improving skin cancer therapy.